• 18461 Citations
1978 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
1993

Transition metals in control of gene expression

O'Halloran, T. V., Jan 1 1993, In : Science. 261, 5122, p. 715-725 11 p.

Research output: Contribution to journalReview article

526 Scopus citations
1996

Metal-responsive gene regulation and the zinc metalloregulatory model.

Suhy, D. A. & O'Halloran, T. V., 1996, In : Metal ions in biological systems. 32, p. 557-578 22 p.

Research output: Contribution to journalReview article

22 Scopus citations
2000

Structure and chemistry of the copper chaperone proteins

Rosenzweig, A. C. & O'Halloran, T. V., Apr 1 2000, In : Current Opinion in Chemical Biology. 4, 2, p. 140-147 8 p.

Research output: Contribution to journalReview article

153 Scopus citations
2001

Function, structure, and mechanism of intracellular copper trafficking proteins

Huffman, D. L. & O'Halloran, T. V., Jul 30 2001, In : Annual review of biochemistry. 70, p. 677-701 25 p.

Research output: Contribution to journalReview article

384 Scopus citations
2003

Transition metal speciation in the cell: Insights from the chemistry of metal ion receptors

Finney, L. A. & O'Halloran, T. V., May 9 2003, In : Science. 300, 5621, p. 931-936 6 p.

Research output: Contribution to journalReview article

833 Scopus citations
2006

Activation of superoxide dismutases: Putting the metal to the pedal

Culotta, V. C., Yang, M. & O'Halloran, T. V., Jul 1 2006, In : Biochimica et Biophysica Acta - Molecular Cell Research. 1763, 7, p. 747-758 12 p.

Research output: Contribution to journalReview article

338 Scopus citations

Posttranslational modifications in Cu,Zn-superoxide dismutase and mutations associated with amyptrophic lateral sclerosis

Furukawa, Y. & O'Halloran, T. V., May 1 2006, In : Antioxidants and Redox Signaling. 8, 5-6, p. 847-867 21 p.

Research output: Contribution to journalReview article

93 Scopus citations
2011

Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic

Mazar, A. P., Ahn, R. W. & O'Halloran, T. V., Jun 2011, In : Current Pharmaceutical Design. 17, 19, p. 1970-1978 9 p.

Research output: Contribution to journalReview article

45 Scopus citations
2013

The many spaces of uPAR: Delivery of theranostic agents and nanobins to multiple tumor compartments through a single target

O'Halloran, T. V., Ahn, R., Hankins, P., Swindell, E. & Mazar, A. P., Sep 3 2013, In : Theranostics. 3, 7, p. 496-506 11 p.

Research output: Contribution to journalReview article

26 Scopus citations

Zinc, insulin, and the liver: A ménage à trois

O'Halloran, T. V., Kebede, M., Philips, S. J. & Attie, A. D., Oct 1 2013, In : Journal of Clinical Investigation. 123, 10, p. 4136-4139 4 p.

Research output: Contribution to journalReview article

21 Scopus citations
2019

Beyond cisplatin: Combination therapy with arsenic trioxide

Miodragović, Ð., Swindell, E. P., Sattar Waxali, Z., Bogachkov, A. & O'Halloran, T. V., Oct 1 2019, In : Inorganica Chimica Acta. 496, 119030.

Research output: Contribution to journalReview article

5 Scopus citations